International trade · 23/04/2015Updated: 10/17/2026 · 1 min read
U.S. International Trade Commission Seeks Public Comments on Recombinant Factor VIII Products Complaint
Summary
The U.S. International Trade Commission has received a complaint about Certain Recombinant Factor VIII Products and is now seeking public comments on any issues related to the public interest